UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study

European journal of neurology, 2018-02, Vol.25 (2), p.320-325

2018

Volltextzugriff (PDF)

AB0008 APPLYING WHOLE EXOME SEQUENCING TO FAMILIAL ANTIPHOSPHOLIPID SYNDROME: NEW PLAYERS IN A RARE DISEASE?

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1039-1039

2021

Volltextzugriff (PDF)

AB0566 Anti-phospholipid antibodies sero-negativization in systemic lupus erythematosus patients treated with belimumab

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1437-1438

2018

Volltextzugriff (PDF)

Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

Lupus, 2017-11, Vol.26 (13), p.1457-1458

2017

Volltextzugriff (PDF)

FRI0333 B-cells depletion as rescue therapy for extra-criteria manifestations of primary antiphospholipid syndrome

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.703

2018

Volltextzugriff (PDF)

SAT0477 Intensified b-cell depletion therapy in progressive systemic sclerosispatients: 24 months follow-up

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1096

2018

Volltextzugriff (PDF)

THU0367 Prevalence and significance of anti-phosphatidylserine antibodies: a pooled analysis in 5992 patients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.400

2018

Volltextzugriff (PDF)

AB0666 Clinical and serological outcomes of patients with giant cell arteritis treated with tocilizumab or abatacept as steroid-sparing agents

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1477

2018

Volltextzugriff (PDF)

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

Journal of internal medicine, 2018-07, Vol.284 (1), p.61-77

2018

Volltextzugriff (PDF)

AB0657 Cyclophosphamide-sparing role of an intensified b-cell depletion protocol in anca-associated vasculitis: a case-control study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1473

2018

Volltextzugriff (PDF)

THU0360 A validation study of the global antiphospholipid syndrome score (GAPSS) in women with systemic lupus erythematosus and pregnancy morbidity

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.397

2018

Volltextzugriff (PDF)

FRI0327 Reliability of la and diagnostic performance of aps/pt in different clinical settings of aps: a multicenter study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.700

2018

Volltextzugriff (PDF)

THU0076 Antibodies to citrullinated protein antigens (ACPAS) induce adipose tissue dysfunction impairing adipocyte differentiation, lipid accumulation and promoting macrophage polarisation. in vitro effect of biologic dmards

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.261

2018

Volltextzugriff (PDF)

THU0635 Pregnancy outcomes in mixed connective tissue disease: results from a multicentre cohort study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.513

2018

Volltextzugriff (PDF)

OP0201 Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicenter cohort study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.149

2018

Volltextzugriff (PDF)

THU0074 Effects of rituximab on the inflammatory and pro-thrombotic profiles of non-b cells of the immune and vascular systems of rheumatoid arthritis and systemic lupus erythematosus patients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.260

2018

Volltextzugriff (PDF)

AB0152 Microarrays gene expression profiling of monocytes from systemic lupus erythematosus patients: novel genes and pathways involved in the disease

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1266

2018

Volltextzugriff (PDF)

AB1002 IDIOPATHIC FULL-HOUSE NON-LUPUS NEPHROPATHY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1817-1818

2024

Volltextzugriff (PDF)

POS1448 DICKKOPF HOMOLOG 3 (DKK3) AS A PROGNOSTIC MARKER IN LUPUS NEPHRITIS: A PROSPECTIVE MONOCENTRIC EXPERIENCE

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1069-1069

2022

Volltextzugriff (PDF)

POS1409 NEW INSIGHTS INTO THE ANTIPHOSPHOLIPID SYNDROME SPECTRUM: FROM ANTIPHOSPHOLIPID ANTIBODIES POSITIVE SUBJECTS PROFILING TO IDENTIFICATION OF SYSTEMIC APS SUBSET THROUGH TYPE I INTERFERON PATHWAY ACTIVATION

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1058-1058

2023

Volltextzugriff (PDF)

POS0726 THE PERFORMANCE OF THE 2023 ACR/EULAR APS CRITERIA IN CURRENT RESEARCH COHORTS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.542-542

2024

Volltextzugriff (PDF)

AB0088 QUALITY OF LIFE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES DIFFERS ACCORDING TO ANTIPHOSPHOLIPID SYNDROME DAMAGE INDEX (DIAPS)

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1073-1074

2021

Volltextzugriff (PDF)

AB1433 ASSESSING THE CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: QRISK AND GAPSS SCORES HEAD TO HEAD

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1822-1823

2022

Volltextzugriff (PDF)

POS0092 HETEROGENEITY OF THE TYPE I INTERFERON SIGNATURE AMONG ANTIPHOSPHOLIPID SYNDROME PATIENTS: A CLUSTER AND CORRESPONDENCE ANALYSIS APPROACH

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.267-268

2022

Volltextzugriff (PDF)

POS0507 TAILORING ORAL THERAPY IN RHEUMATOID ARTHRITIS: THE TuTOR APP

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.508-509

2022

Volltextzugriff (PDF)

1 – 25 von 1.110

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.073)
Mit Volltextzugriff
(958)

Publikationsform

Artikel
(1.086)
Berichte
(23)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(681)
Life Sciences & Biomedicine
(624)
Humans
(450)
Male
(270)
Female
(266)
Middle Aged
(166)
Adult
(153)
Biological And Medical Sciences
(146)
Cardiovascular System & Cardiology
(138)
Aged
(137)
Cardiac & Cardiovascular Systems
(120)
Medical Sciences
(118)
Animals
(100)
Neurosciences & Neurology
(84)
Allergy
(74)
Immunology
(72)
Patients
(71)
Neurosciences
(68)
Life Sciences
(67)
Risk Factors
(58)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study

AB0008 APPLYING WHOLE EXOME SEQUENCING TO FAMILIAL ANTIPHOSPHOLIPID SYNDROME: NEW PLAYERS IN A RARE DISEASE?

AB0566 Anti-phospholipid antibodies sero-negativization in systemic lupus erythematosus patients treated with belimumab

Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

FRI0333 B-cells depletion as rescue therapy for extra-criteria manifestations of primary antiphospholipid syndrome

SAT0477 Intensified b-cell depletion therapy in progressive systemic sclerosispatients: 24 months follow-up

THU0367 Prevalence and significance of anti-phosphatidylserine antibodies: a pooled analysis in 5992 patients

AB0666 Clinical and serological outcomes of patients with giant cell arteritis treated with tocilizumab or abatacept as steroid-sparing agents

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

AB0657 Cyclophosphamide-sparing role of an intensified b-cell depletion protocol in anca-associated vasculitis: a case-control study

THU0360 A validation study of the global antiphospholipid syndrome score (GAPSS) in women with systemic lupus erythematosus and pregnancy morbidity

FRI0327 Reliability of la and diagnostic performance of aps/pt in different clinical settings of aps: a multicenter study

THU0076 Antibodies to citrullinated protein antigens (ACPAS) induce adipose tissue dysfunction impairing adipocyte differentiation, lipid accumulation and promoting macrophage polarisation. in vitro effect of biologic dmards

THU0635 Pregnancy outcomes in mixed connective tissue disease: results from a multicentre cohort study

OP0201 Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicenter cohort study

THU0074 Effects of rituximab on the inflammatory and pro-thrombotic profiles of non-b cells of the immune and vascular systems of rheumatoid arthritis and systemic lupus erythematosus patients

AB0152 Microarrays gene expression profiling of monocytes from systemic lupus erythematosus patients: novel genes and pathways involved in the disease

AB1002 IDIOPATHIC FULL-HOUSE NON-LUPUS NEPHROPATHY

POS1448 DICKKOPF HOMOLOG 3 (DKK3) AS A PROGNOSTIC MARKER IN LUPUS NEPHRITIS: A PROSPECTIVE MONOCENTRIC EXPERIENCE

POS1409 NEW INSIGHTS INTO THE ANTIPHOSPHOLIPID SYNDROME SPECTRUM: FROM ANTIPHOSPHOLIPID ANTIBODIES POSITIVE SUBJECTS PROFILING TO IDENTIFICATION OF SYSTEMIC APS SUBSET THROUGH TYPE I INTERFERON PATHWAY ACTIVATION

POS0726 THE PERFORMANCE OF THE 2023 ACR/EULAR APS CRITERIA IN CURRENT RESEARCH COHORTS

AB0088 QUALITY OF LIFE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES DIFFERS ACCORDING TO ANTIPHOSPHOLIPID SYNDROME DAMAGE INDEX (DIAPS)

AB1433 ASSESSING THE CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: QRISK AND GAPSS SCORES HEAD TO HEAD

POS0092 HETEROGENEITY OF THE TYPE I INTERFERON SIGNATURE AMONG ANTIPHOSPHOLIPID SYNDROME PATIENTS: A CLUSTER AND CORRESPONDENCE ANALYSIS APPROACH

POS0507 TAILORING ORAL THERAPY IN RHEUMATOID ARTHRITIS: THE TuTOR APP

Aktive Filter

Suchergebnisse filtern